Searched for
COVISHIELD HEALTH CONCERN
Covaxin, Covishield alert: Scammers exploiting vaccine fears, police issue alertAuthorities are alarmed by a surge in fraudulent activities exploiting Covid-19 vaccine inquiries, targeting unsuspecting individuals for p...- Bollywood celebs express concern over Covishield vaccine's side effects: What they saidAstraZeneca's recent disclosure about Covishield's rare but serious side effects has sparked concerns among both medical professionals and ...
- SII urges govt to fast-track movement of increasing Covishield stockPrakash Kumar Singh, Director, Government and Regulatory Affairs at SII, is learnt to have recently communicated to the Union Health Minist...
- Cannot play with lives of people by directing revaccination with Covishield without any data: SCThe Supreme Court said that it cannot play with the lives of people by directing the Centre to revaccinate people with Covishield who are f...
- Many Indians unlikely to be fully vaccinated by year-end despite ample COVID-19 shotsThe locally-produced AstraZeneca vaccine which is known as Covishield has a 12 to 16 week gap between doses, in contrast to the 8 to 12 wee...
- UK rule of 10-day quarantine for those vaccinated in India discriminatory: GovernmentFollowing India's strong criticism over the UK's refusal to recognise Covishield, London amended its new guidelines to include the Indian-m...
- Centre places purchase order with SII for 66 crore Covishield doses to be supplied by December, say sourcesThe development comes after Prakash Kumar Singh, the Director, Government and Regulatory Affairs at SII, informed the Union Health Ministry...
- No talk of Covid booster shots yet, plan to jab adult population first: Niti Aayog member VK PaulIn response to the chairman of the Serum Institute of India, Cyrus Poonawalla, emphasising the necessity for a third or booster dosage of C...
- Individuals who recovered from Covid and are vaccinated have higher protection against Delta variant, shows studyThere is limited information available on the duration of protective immune response post-infection, vaccination or breakthrough infection.
- Serum's Covishield cleared by 7 European Union nations and SwitzerlandRecognition of the India-made vaccines would be reciprocated and holders of the EU inoculation pass will be exempted from mandatory quarant...
- Won't accept EU vaccine certificates unless it considers Covishield, Covaxin for Green Passport, says IndiaIndia has conveyed to the EU member states that it will adopt a policy of reciprocity and exempt European nationals holding the 'Green Pass...
- Individual states can accept Covishield vaccine certificates, says European UnionThis comes after the issue of Covishield’s exclusion from EU Green Pass threatened to snowball into a crisis with the African CDC issuing a...
- India needs to shorten Covishield dose gap: Health experts“The current gap of 12 to 16 weeks has two problems: first, it leaves people with one dose exposed for that much time to the risk of severe...
- Govt increases interval between Covishield doses to 12-16 weeks; says the decision is 'science-based'"Based on the available real-life evidences, particularly from the UK, the COVID-19 Working Group agreed for increasing the dosing interval...
- Centre allays concerns on Covishield vaccineCovishield is safe and there is 'no signal of concern' regarding it as of now, the Centre asserted on Wednesday amid reports of possible si...
- Centre says both COVID-19 vaccines in India effective against British and Brazilian variants"Please don't spread doubt. As of today, these vaccines work on the good old virus as well as the new variants," NITI Aayog member (Health)...
- Panel finds no causal link yet between Covid jabs and deaths“We have investigated the deaths by reviewing the post mortem reports, discharge summary among others and not found any link between deaths...
- Panel on jab adverse events to take stockThe National Adverse Events Following Immunisation (AEFI) Committee meeting will take place in the wake of some European nations such as Ge...
- Chhattisgarh still won't use Covaxin till Phase 3 trial data available: T S Singh DeoA day after health minister Harsh Vardhan wrote to Singh Deo saying fears against Covaxin were unfounded and the state should use both Cova...
- Covishield and Covaxin: Key concerns over the two vaccinesET tries to clear some concerns around the development with experts’ views on how the two vaccines can be used for India’s public vaccinati...
Load More
